Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.

Carrithers SL, Barber MT, Biswas S, Parkinson SJ, Park PK, Goldstein SD, Waldman SA.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14827-32.

PMID:
8962140
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.

Frick GS, Pitari GM, Weinberg DS, Hyslop T, Schulz S, Waldman SA.

Expert Rev Mol Diagn. 2005 Sep;5(5):701-13. Review.

PMID:
16149873
[PubMed - indexed for MEDLINE]
3.

Escherichia coli heat-stable enterotoxin receptors. A novel marker for colorectal tumors.

Carrithers SL, Parkinson SJ, Goldstein SD, Park PK, Urbanski RW, Waldman SA.

Dis Colon Rectum. 1996 Feb;39(2):171-81.

PMID:
8620784
[PubMed - indexed for MEDLINE]
4.

Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro.

Waldman SA, Barber M, Pearlman J, Park J, George R, Parkinson SJ.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):505-14.

PMID:
9641495
[PubMed - indexed for MEDLINE]
Free Article
5.

A splice variant of the transcript for guanylyl cyclase C is expressed in human colon and colorectal cancer cells.

Pearlman JM, Prawer SP, Barber MT, Parkinson SJ, Schulz S, Park J, Zook M, Waldman SA.

Dig Dis Sci. 2000 Feb;45(2):298-305.

PMID:
10711442
[PubMed - indexed for MEDLINE]
6.

Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.

Waldman SA, Cagir B, Rakinic J, Fry RD, Goldstein SD, Isenberg G, Barber M, Biswas S, Minimo C, Palazzo J, Park PK, Weinberg D.

Dis Colon Rectum. 1998 Mar;41(3):310-5.

PMID:
9514425
[PubMed - indexed for MEDLINE]
7.

A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.

Schulz S, Hyslop T, Haaf J, Bonaccorso C, Nielsen K, Witek ME, Birbe R, Palazzo J, Weinberg D, Waldman SA.

Clin Cancer Res. 2006 Aug 1;12(15):4545-52.

PMID:
16899600
[PubMed - indexed for MEDLINE]
Free Article
8.

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.

Cagir B, Gelmann A, Park J, Fava T, Tankelevitch A, Bittner EW, Weaver EJ, Palazzo JP, Weinberg D, Fry RD, Waldman SA.

Ann Intern Med. 1999 Dec 7;131(11):805-12.

PMID:
10610624
[PubMed - indexed for MEDLINE]
9.

Guanylyl cyclase C is a specific marker for differentiating primary and metastatic ovarian mucinous neoplasms.

Ciocca V, Bombonati A, Palazzo JP, Schulz S, Waldman SA.

Histopathology. 2009 Aug;55(2):182-8. doi: 10.1111/j.1365-2559.2009.03358.x.

PMID:
19694825
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9.

Lubbe WJ, Zuzga DS, Zhou Z, Fu W, Pelta-Heller J, Muschel RJ, Waldman SA, Pitari GM.

Cancer Res. 2009 Apr 15;69(8):3529-36. doi: 10.1158/0008-5472.CAN-09-0067. Epub 2009 Mar 31.

PMID:
19336567
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.

Fava TA, Desnoyers R, Schulz S, Park J, Weinberg D, Mitchell E, Waldman SA.

J Clin Oncol. 2001 Oct 1;19(19):3951-9.

PMID:
11579116
[PubMed - indexed for MEDLINE]
Free Article
12.

Guanylyl cyclase C as a reliable immunohistochemical marker and its ligand Escherichia coli heat-stable enterotoxin as a potential protein-delivering vehicle for colorectal cancer cells.

Buc E, Vartanian MD, Darcha C, D├ęchelotte P, Pezet D.

Eur J Cancer. 2005 Jul;41(11):1618-27.

PMID:
15919201
[PubMed - indexed for MEDLINE]
13.

Previstage GCC test for staging patients with colorectal cancer.

Mejia A, Waldmana SA.

Expert Rev Mol Diagn. 2008 Sep;8(5):571-8. doi: 10.1586/14737159.8.5.571.

PMID:
18785805
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Peripheral blood guanylyl cyclase c (GCC) expressions are associated with prognostic parameters and response to therapy in colorectal cancer patients.

Camci C, Sahin A, Sevinc A, Kalender ME, Oztuzcu S, Sever ON, Ozkara E, Demiry├╝rek AT.

Tumour Biol. 2011 Dec;32(6):1265-70. doi: 10.1007/s13277-011-0231-0. Epub 2011 Sep 8.

PMID:
21901559
[PubMed - indexed for MEDLINE]
15.

In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand.

Wolfe HR, Mendizabal M, Lleong E, Cuthbertson A, Desai V, Pullan S, Fujii DK, Morrison M, Pither R, Waldman SA.

J Nucl Med. 2002 Mar;43(3):392-9.

PMID:
11884500
[PubMed - indexed for MEDLINE]
Free Article
16.
17.

Expression of the intestinal biomarkers Guanylyl cyclase C and CDX2 in poorly differentiated colorectal carcinomas.

Winn B, Tavares R, Matoso A, Noble L, Fanion J, Waldman SA, Resnick MB.

Hum Pathol. 2010 Jan;41(1):123-8. doi: 10.1016/j.humpath.2009.07.009. Epub 2009 Oct 1.

PMID:
19800103
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Colorectal cancer is a paracrine deficiency syndrome amenable to oral hormone replacement therapy.

Li P, Lin JE, Snook AE, Gibbons AV, Zuzga DS, Schulz S, Pitari GM, Waldman SA.

Clin Transl Sci. 2008 Sep;1(2):163-7. doi: 10.1111/j.1752-8062.2008.00040.x.

PMID:
19727435
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.

Waldman SA, Hyslop T, Schulz S, Barkun A, Nielsen K, Haaf J, Bonaccorso C, Li Y, Weinberg DS.

JAMA. 2009 Feb 18;301(7):745-52. doi: 10.1001/jama.2009.141.

PMID:
19224751
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.

Engelhardt M, Drullinsky P, Guillem J, Moore MA.

Clin Cancer Res. 1997 Nov;3(11):1931-41.

PMID:
9815582
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk